Results 41 to 50 of about 588 (176)

The role of drug, dose and the tolerance/intolerance of new drugs in multiple drug hypersensitivity syndrome (MDH). [PDF]

open access: yes, 2020
BACKGROUND Multiple drug hypersensitivity syndrome (MDH) is used to describe persons with a drug hypersensitivity reaction (DHR) to at least two chemically unrelated drugs, confirmed by skin test or in vitro assay.
Helbling, Arthur   +3 more
core   +1 more source

Analysis of cutaneous adverse drug reactions in a tertiary care hospital in South Tamil Nadu [PDF]

open access: yes, 2022
Background: Cutaneous adverse drug reactions (CADRs) are among the most frequently reported adverse drug reactions (10 to 30%) with overall incidence of 6.2/1000 cases in India and 8% of hospitalisation among Dermatology inpatients.
B., Meenakshi   +3 more
core   +2 more sources

Adverse cutaneous drug reactions reporting in a tertiary care teaching hospital in Eastern India: a retrospective study [PDF]

open access: yes, 2020
Background: Any unwanted changes to mucous membrane, skin, its appendages and drug eruptions related adverse events are known as adverse cutaneous drug reaction (ACDR). It has 2-5% incidence in developing countries.
Bose, Manika   +5 more
core   +2 more sources

Symmetrical Drug-Related Intertriginous and Flexural Exanthema Induced by Cellulitis Prophylaxis [PDF]

open access: yes, 2021
Penicillin VK and hydroxyzine are typically well-tolerated antipruritic agents that are indicated in the prophylaxis of cellulitis. We herein report a case of a unique rash occurring during penicillin VK and hydroxyzine treatment in combination with the ...
Lee, Erica   +5 more
core   +1 more source

The Dermatological Spectrum of Coronavirus Disease-19 Disease: Cutaneous Signs for Diagnostics and Prognosis and an Expanded Classification: COVID-19 and skin [PDF]

open access: yes, 2020
During severe acute respiratory syndrome coronavirus (CoV)-2- induced CoV disease (COVID)-19 pandemic cutaneous signs of the disease gained increasing interest for early diagnosis, to establish a prognosis and for differential diagnoses.
Chiriac, Anca   +2 more
core   +2 more sources

Skin manifestations in patients with coronavirus disease 2019 [PDF]

open access: yes, 2022
Purpose of review: Coronavirus disease 2019 (COVID-19) is a well established respiratory tract illness. Recent studies in adults and children have shown an increasing number of patients reporting polymorphic cutaneous manifestations during COVID-19 ...
Bassetti, Matteo   +6 more
core   +1 more source

Systemic drug-related intertriginous and flexural exanthema (SDRIFE)

open access: yesDermatology Online Journal, 2009
A 72-year-old man with a history of metastatic melanoma presented with a two-day history of erythematous and edematous plaques, with scattered bullae on the neck, chest, axillae, and inguinal and gluteal folds, which began five days after infusion of an experimental drug.
Elmariah, Sarina B   +4 more
openaire   +4 more sources

Case report-baboon syndrome with paracetamol [PDF]

open access: yes, 2018
Adverse drug reaction (ADR) is defined as “any response to drug which is noxious or unintended and occurs at a dose normally used in man for prophylaxis, diagnosis or treatment of diseases or for modification of physiological function”.
B., Roopa   +3 more
core   +2 more sources

Baboon Syndrome Caused by Anti-Haemorrhoidal Ointment [PDF]

open access: yes, 2018
info:eu-repo/semantics ...
Brinca   +5 more
core   +1 more source

Skin tests in the diagnosis of adverse drug reactions: a systematic review [PDF]

open access: yes, 2020
Adverse Drug Reactions (ADRs) are common and influence negatively the patient's therapeutic options. They recognize multiple pathogenic mechanisms, some of immunological origin, and the clinical manifestations involve several organs and systems ...
Bianchi, Leonardo   +11 more
core   +1 more source

Home - About - Disclaimer - Privacy